Predictive and prognostic role of fragile histidine triad (FHIT) and P53 gene inactivaton in non-small-cell lung cancer (NSCLC) patients treated with platinum-analogue regimen

被引：0
|
作者：
Cortinovis, D.
Bajetta, E.
Sozzi, G.
Mariani, L.
Fabbri, A.
Livio, A.
Roz, L.
Andriani, F.
Perego, P.
Zilembo, N.
Formisano, B.
Bidoli, P.
机构：
[1] Ist Nazl Studio & Cura Tumori, Med Oncol Unit 2, I-20133 Milan, Italy
[2] Ist Nazl Studio & Cura Tumori, Dept Expt Oncol, I-20133 Milan, Italy
[3] Ist Nazl Studio & Cura Tumori, Dept Med Stat, I-20133 Milan, Italy
[4] Ist Nazl Studio & Cura Tumori, Anat Pathol Unit, I-20133 Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI19 / XI19
页数：1
相关论文
共 50 条
  • [31] P53 codon 72 polymorphism increases the risk of somatic P53 gene mutations in non-small cell lung cancer (NSCLC)
    Szymanowska, A
    Jassem, E
    Dziadziuszko, R
    Borg, A
    Limon, J
    Kobierska-Gulida, G
    Skokowski, J
    Jassem, J
    LUNG CANCER, 2005, 49 : S75 - S75
  • [32] Relation between P53 codon 72 polymorphism and somatic P53 gene mutation in non-small cell lung cancer (NSCLC)
    Jassem, J.
    Szymanowska, A.
    Jassem, E.
    Dziadziuszko, R.
    Borg, A.
    Limon, J.
    Kobierska-Gulida, G.
    Skokowski, J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 336 - 336
  • [33] Expression of p16 and p53 in non-small-cell lung cancer: clinicopathological correlation and potential prognostic impact
    Zhou, Yangying
    Hoti, Naseruddin
    Ao, Minghui
    Zhang, Zhen
    Zhu, Hong
    Li, Ling
    Askin, Frederic
    Gabrielson, Edward
    Zhang, Hui
    Li, Qing Kay
    BIOMARKERS IN MEDICINE, 2019, 13 (09) : 761 - 771
  • [34] THE PROGNOSTIC-SIGNIFICANCE OF ACCUMULATION OF P53 PROTEIN IN STAGE-III NON-SMALL-CELL LUNG-CANCER TREATED BY RADIOTHERAPY
    LANGENDIJK, JA
    THUNNISSEN, FBJM
    LAMERS, RJS
    DEJONG, JMA
    TENVELDE, GPM
    WOUTERS, EFM
    RADIOTHERAPY AND ONCOLOGY, 1995, 36 (03) : 218 - 224
  • [35] Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib
    Satouchi, M.
    Negoro, S.
    Funada, Y.
    Urata, Y.
    Shimada, T.
    Yoshimura, S.
    Kotani, Y.
    Sakuma, T.
    Watanabe, H.
    Adachi, S.
    Takada, Y.
    Yatabe, Y.
    Mitsudomi, T.
    BRITISH JOURNAL OF CANCER, 2007, 96 (08) : 1191 - 1196
  • [36] p53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survival
    Mitsudomi, T
    Oyama, T
    Nishida, K
    Ogami, A
    Osaki, T
    Nakanishi, R
    Sugio, K
    Yasumoto, K
    Sugimachi, K
    ANNALS OF ONCOLOGY, 1995, 6 : 9 - 13
  • [37] Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib
    M Satouchi
    S Negoro
    Y Funada
    Y Urata
    T Shimada
    S Yoshimura
    Y Kotani
    T Sakuma
    H Watanabe
    S Adachi
    Y Takada
    Y Yatabe
    T Mitsudomi
    British Journal of Cancer, 2007, 96 : 1191 - 1196
  • [38] Cyclin D1 overexpression in correlation with pRb and p53 status in non-small-cell lung cancer (NSCLC)
    Dworakowska, D
    Jassem, E
    Jassem, J
    Boltze, C
    Wiedorn, KH
    Karmolinski, A
    Dworakowski, R
    Lapinski, M
    Tomaszewski, D
    Skokowski, J
    Jaskiewicz, K
    Czestochowska, E
    LUNG CANCER, 2004, 45 : S31 - S31
  • [39] Predictive value of EGFR mutation in non-small-cell lung cancer patients treated with platinum doublet postoperative chemotherapy
    Takahashi, Toshiaki
    Sakai, Kazuko
    Kenmotsu, Hirotsugu
    Yoh, Kiyotaka
    Daga, Haruko
    Ohira, Tatsuo
    Ueno, Tsuyoshi
    Aoki, Tadashi
    Hayashi, Hidetoshi
    Yamazaki, Koji
    Hosomi, Yukio
    Chen-Yoshikawa, Toyofumi F.
    Okumura, Norihito
    Takiguchi, Yuichi
    Sekine, Akimasa
    Haruki, Tomohiro
    Yamamoto, Hiromasa
    Sato, Yuki
    Akamatsu, Hiroaki
    Seto, Takashi
    Saeki, Sho
    Sugio, Kenji
    Nishio, Makoto
    Inokawa, Hidetoshi
    Yamamoto, Nobuyuki
    Nishio, Kazuto
    Tsuboi, Masahiro
    CANCER SCIENCE, 2022, 113 (01) : 287 - 296
  • [40] Role of p53 and EGFR as Prognostic Biomarkers in Stage I Non-Small Cell Lung Cancer
    Donahue, James M.
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 110 (02) : 97 - 98
12345